NYSE:WST - West Pharmaceutical Services Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $106.46 -0.45 (-0.42 %) (As of 11/14/2018 04:00 PM ET)Previous Close$106.91Today's Range$106.30 - $108.215052-Week Range$82.74 - $125.09Volume170,271 shsAverage Volume378,529 shsMarket Capitalization$7.92 billionP/E Ratio38.29Dividend Yield0.56%Beta1.19 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. Receive WST News and Ratings via Email Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Fabricated rubber products, not elsewhere classified Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNYSE:WST Previous Symbol CUSIP95530610 Webwww.westpharma.com Phone610-594-2900 Debt Debt-to-Equity Ratio0.15 Current Ratio2.94 Quick Ratio2.23 Price-To-Earnings Trailing P/E Ratio38.29 Forward P/E Ratio38.02 P/E Growth4.04 Sales & Book Value Annual Sales$1.60 billion Price / Sales4.93 Cash Flow$4.1216 per share Price / Cash25.83 Book Value$18.25 per share Price / Book5.83 Profitability EPS (Most Recent Fiscal Year)$2.78 Net Income$150.70 million Net Margins9.06% Return on Equity15.78% Return on Assets10.90% Miscellaneous Employees7,500 Outstanding Shares74,080,000Market Cap$7.92 billion OptionableOptionable West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions What is West Pharmaceutical Services' stock symbol? West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST." How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services? West Pharmaceutical Services declared a quarterly dividend on Thursday, May 3rd. Shareholders of record on Wednesday, October 24th will be paid a dividend of $0.15 per share on Wednesday, November 7th. This represents a $0.60 annualized dividend and a yield of 0.56%. The ex-dividend date is Tuesday, October 23rd. This is a positive change from West Pharmaceutical Services's previous quarterly dividend of $0.14. View West Pharmaceutical Services' Dividend History. How will West Pharmaceutical Services' stock buyback program work? West Pharmaceutical Services announced that its board has approved a share buyback program on Thursday, February 15th 2018, which permits the company to repurchase 800,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's board believes its stock is undervalued. How were West Pharmaceutical Services' earnings last quarter? West Pharmaceutical Services Inc. (NYSE:WST) released its earnings results on Thursday, October, 25th. The medical instruments supplier reported $0.76 EPS for the quarter, topping the consensus estimate of $0.70 by $0.06. The medical instruments supplier earned $431.70 million during the quarter, compared to analysts' expectations of $427.55 million. West Pharmaceutical Services had a net margin of 9.06% and a return on equity of 15.78%. View West Pharmaceutical Services' Earnings History. When is West Pharmaceutical Services' next earnings date? West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, February 21st 2019. View Earnings Estimates for West Pharmaceutical Services. What guidance has West Pharmaceutical Services issued on next quarter's earnings? West Pharmaceutical Services issued an update on its FY 2018 earnings guidance on Thursday, October, 25th. The company provided earnings per share (EPS) guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.82. The company issued revenue guidance of $1.72-1.73 billion, compared to the consensus revenue estimate of $1.73 billion. What price target have analysts set for WST? 2 brokerages have issued 1 year price targets for West Pharmaceutical Services' shares. Their forecasts range from $85.00 to $110.00. On average, they anticipate West Pharmaceutical Services' share price to reach $97.50 in the next twelve months. This suggests that the stock has a possible downside of 8.4%. View Analyst Price Targets for West Pharmaceutical Services. What is the consensus analysts' recommendation for West Pharmaceutical Services? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services. Has West Pharmaceutical Services been receiving favorable news coverage? News coverage about WST stock has been trending somewhat negative recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. West Pharmaceutical Services earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. Who are some of West Pharmaceutical Services' key competitors? Some companies that are related to West Pharmaceutical Services include Takeda Pharmaceutical (TKPYY), Edwards Lifesciences (EW), Actelion (ALIOF), ASTELLAS PHARMA/ADR (ALPMY), ESSILOR Intl S/S (ESLOY), Centene (CNC), Eisai (ESALY), Alexion Pharmaceuticals (ALXN), McKesson (MCK), Teva Pharmaceutical Industries (TEVA), Fresenius Medical Care AG & Co. (FMS), Zimmer Biomet (ZBH), LONZA GRP AG/ADR (LZAGY), TERUMO Corp/ADR (TRUMY) and AmerisourceBergen (ABC). Who are West Pharmaceutical Services' key executives? West Pharmaceutical Services' management team includes the folowing people: Mr. Eric M. Green, CEO, Pres & Director (Age 48)Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 63)Ms. Annette F. Favorite, Chief HR Officer and Sr. VP (Age 53)Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 55)Mr. William J. Federici, Advisor (Age 58) Who are West Pharmaceutical Services' major shareholders? West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.96%), Franklin Resources Inc. (6.53%), Alliancebernstein L.P. (2.96%), JPMorgan Chase & Co. (2.21%), Bamco Inc. NY (2.18%) and William Blair Investment Management LLC (1.94%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services. Which institutional investors are selling West Pharmaceutical Services stock? WST stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., JPMorgan Chase & Co., William Blair Investment Management LLC, Schroder Investment Management Group, Eagle Asset Management Inc., Victory Capital Management Inc., Renaissance Technologies LLC and AMI Asset Management Corp. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone, Karen Flynn and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services. Which institutional investors are buying West Pharmaceutical Services stock? WST stock was acquired by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Massachusetts Financial Services Co. MA, Kornitzer Capital Management Inc. KS, Riverbridge Partners LLC, Prudential Financial Inc., Franklin Resources Inc., Cornerstone Wealth Management LLC and BlackRock Inc.. View Insider Buying and Selling for West Pharmaceutical Services. How do I buy shares of West Pharmaceutical Services? Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is West Pharmaceutical Services' stock price today? One share of WST stock can currently be purchased for approximately $106.46. How big of a company is West Pharmaceutical Services? West Pharmaceutical Services has a market capitalization of $7.92 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $2.78 on an earnings per share basis. West Pharmaceutical Services employs 7,500 workers across the globe. What is West Pharmaceutical Services' official website? The official website for West Pharmaceutical Services is http://www.westpharma.com. How can I contact West Pharmaceutical Services? West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected] MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)Community Ranking: 1.8 out of 5 ()Outperform Votes: 165 (Vote Outperform)Underperform Votes: 281 (Vote Underperform)Total Votes: 446MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/14/2018 by MarketBeat.com StaffFeatured Article: What is an Initial Public Offering (IPO)?